Black Rock Inc. Dexcom Inc Call Options Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $31.1 Million - $38.1 Million	272,000 New	272,000 $37.7 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $21.9 Million - $27.1 Million	287,300 Added 481.24%	347,000 $27.9 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $90,909 - $113,974	-700 Reduced 1.16%	59,700 $32.1 Million
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $6.45 Million - $8.65 Million	60,400 New	60,400 $33 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.